Loukas Settas

1.6k citations
28 papers · 1.3k · 1 hit paper · h-index 16

Impact in

    • Rheumatoid Arthritis Research and Therapies
    • Systemic Lupus Erythematosus Research
    • Spondyloarthritis Studies and Treatments
  • Hematology top 5%
    • Autoimmune and Inflammatory Disorders Research

Papers in

    • Rheumatoid Arthritis Research and Therapies 9
    • Systemic Lupus Erythematosus Research 8
    • Spondyloarthritis Studies and Treatments 2
    • Systemic Sclerosis and Related Diseases 8

Loukas Settas

27 papers receiving 1.2k citations

Loukas Settas's Hit Papers

Efficacy and safety of adalimumab as monotherapy in patients with rheumatoid arthritis for whom previous disease modifying antirheumatic drug treatment has failed 2004 · 528 citations
5280+7+14Years since publication100200300400500

Peers

Loukas Settas
Comparison fields: 5 of 76
  • Rheumatology 770
  • Hematology 226
  • Pathology and Forensic Medicine 204
  • Immunology 243
  • Genetics 65
Replace M. Taraborelli with:
M. Taraborelli Italy
Yehuda Shoenfeld Israel
Simona Truglia Italy
Fengchun Zhang China
Micaela Fredi Italy
Francesca Bellisai Italy
P. Nicaise‐Roland France
David Musselman United States
E. L. Matteson United States
Francisco José García Hernández Spain
Loukas Settas relative to M. Taraborelli Italy M. Taraborelli's profile →
Citations per field
00.5×1.5×
M. Taraborelli · 1×
Citations per year

Countries citing papers authored by Loukas Settas

Since Specialization
Citations

This map shows the geographic impact of Loukas Settas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Loukas Settas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Loukas Settas more than expected).

Fields of papers citing papers by Loukas Settas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Loukas Settas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Loukas Settas. The network helps show where Loukas Settas may publish in the future.

Co-authors

The 25 scholars most cited alongside Loukas Settas, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Loukas Settas Line = papers co-authored together Loukas Settas links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Efficacy and safety of adalimumab as monotherapy in patients with rheumatoid arthritis for whom previous disease modifying antirheumatic drug treatment has failed
Hit paper breakdown →
2004528
2 2006110
3 201374
4 198962
5 201154
6 200846
7 201043
8 201643
9 201839
10 200939
11 201035
12 201033
13
Lupus anticoagulant--antiphospholipid antibodies and thrombophilia. Relation to protein C--protein S--thrombomodulin.
199033
14
Clinical expression and course in patients with late onset systemic lupus erythematosus.
201324
15
Association of anti-CCP positivity and carriage of TNFRII susceptibility variant with anti-TNF-α response in rheumatoid arthritis.
201123
16
Safety profile of repeated rituximab cycles in unselected rheumatoid arthritis patients: a long-term, prospective real-life study.
201722
17 200813
18 20179
19 20138
20
Treatment with the first TNF inhibitor in rheumatoid arthritis patients in the Hellenic Registry of Biologic Therapies improves quality of life especially in young patients with better baseline functional status.
20178

About Loukas Settas

Loukas Settas is a scholar working on Rheumatology, Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine, Hematology and Molecular Biology, having authored 28 papers that have together received 1.3k indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (9 papers), Systemic Sclerosis and Related Diseases (8 papers), Systemic Lupus Erythematosus Research (8 papers), Pulmonary Hypertension Research and Treatments (5 papers), Autoimmune and Inflammatory Disorders Research (3 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers), Inflammasome and immune disorders (2 papers) and Spondyloarthritis Studies and Treatments (2 papers). The work is most often cited by research in Rheumatology (770 citations), Hematology (226 citations), Pathology and Forensic Medicine (204 citations), Immunology (243 citations) and Genetics (65 citations). Loukas Settas has collaborated with scholars based in Greece, United States and United Kingdom. Frequent co-authors include Paul Emery, J Sany, Steven Fischkoff, Maxime Dougados, S Todesco, Anthony S. Russell, Michel Malaise, J. W. J. Bijlsma, H. Küpper and Martin Kaul. Their work appears in journals such as Clinical Rheumatology, The Journal of Rheumatology, Seminars in Arthritis and Rheumatism, Annals of the Rheumatic Diseases and Thrombosis and Haemostasis.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact